CORSO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 1.397
AS - Asia 733
EU - Europa 720
SA - Sud America 28
AF - Africa 22
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.920
Nazione #
US - Stati Uniti d'America 1.354
CN - Cina 438
IT - Italia 298
DE - Germania 66
JP - Giappone 64
FR - Francia 63
IN - India 59
GB - Regno Unito 52
VN - Vietnam 41
RU - Federazione Russa 34
CZ - Repubblica Ceca 33
KR - Corea 32
FI - Finlandia 30
NL - Olanda 30
CA - Canada 29
GR - Grecia 22
TW - Taiwan 19
HK - Hong Kong 18
IR - Iran 17
TR - Turchia 16
AU - Australia 15
ES - Italia 15
PT - Portogallo 13
PL - Polonia 10
ZA - Sudafrica 10
CO - Colombia 9
IL - Israele 9
RO - Romania 9
UA - Ucraina 8
MX - Messico 7
PK - Pakistan 7
SE - Svezia 7
BR - Brasile 6
CL - Cile 6
IE - Irlanda 6
CH - Svizzera 5
MA - Marocco 5
MD - Moldavia 4
SG - Singapore 4
BE - Belgio 3
CR - Costa Rica 3
DZ - Algeria 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PE - Perù 3
AT - Austria 2
BD - Bangladesh 2
EC - Ecuador 2
EG - Egitto 2
GT - Guatemala 2
NO - Norvegia 2
TH - Thailandia 2
A1 - Anonimo 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CU - Cuba 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
KZ - Kazakistan 1
ML - Mali 1
NG - Nigeria 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
VE - Venezuela 1
Totale 2.920
Città #
Fairfield 174
Ashburn 102
Santa Cruz 100
Seattle 88
Houston 83
Woodbridge 75
Beijing 64
Cambridge 60
Torino 60
Shanghai 51
Buffalo 50
Ann Arbor 45
Wilmington 39
Shaoxing 30
Lappeenranta 28
Milan 25
Hangzhou 22
Chicago 21
Dong Ket 21
Guangzhou 20
Turin 20
San Diego 19
Tokyo 18
Rome 17
Taipei 16
Bengaluru 14
Chengdu 14
Las Vegas 14
Nanjing 13
University Park 13
Los Angeles 12
Wuhan 12
Hanoi 11
Nanchang 11
Hefei 10
Lake Forest 10
Nanning 10
New York 10
London 9
Wenzhou 9
Boardman 8
Dallas 8
Fuzhou 8
Istanbul 8
Nishimiyahara 8
Seoul 8
Hyderabad 7
Mountain View 7
Muizenberg 7
Athens 6
Barcelona 6
Frankfurt am Main 6
Harbin 6
Kunming 6
Pisa 6
San Antonio 6
Warsaw 6
Xian 6
Amsterdam 5
Bangalore 5
Bogotá 5
Clearwater 5
Council Bluffs 5
Guangdong 5
Lutherville-Timonium 5
Padova 5
Phoenix 5
Providence 5
Riva 5
San Jose 5
Scagnello 5
Tehran 5
Baltimore 4
Boston 4
Chisinau 4
Columbus 4
Dearborn 4
Henderson 4
La Pocatière 4
Madison 4
Ottawa 4
Shenyang 4
Southend 4
Sydney 4
Toronto 4
Westfield 4
Alpharetta 3
Auckland 3
Aurora 3
Avellino 3
Bucharest 3
Caserta 3
Central 3
Central District 3
Des Moines 3
Dublin 3
Duncan 3
Farnborough 3
Gurgaon 3
Hebei 3
Totale 1.711
Nome #
How Can Gastric Cancer Molecular Profiling Guide Future Therapies?, file e27ce429-be45-2581-e053-d805fe0acbaa 418
Targeted therapies for gastric cancer: failures and hopes from clinical trials, file e27ce42b-cd8f-2581-e053-d805fe0acbaa 325
Microsatellite instability in Gastric Cancer: Between lights and shadows, file e27ce434-d10f-2581-e053-d805fe0acbaa 298
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts, file e27ce42c-7d72-2581-e053-d805fe0acbaa 260
Personalized therapeutic strategies in HER2-driven gastric cancer, file e27ce432-5232-2581-e053-d805fe0acbaa 234
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC, file e27ce42c-b21e-2581-e053-d805fe0acbaa 228
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective., file e27ce426-f981-2581-e053-d805fe0acbaa 122
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies, file e27ce42d-ea3c-2581-e053-d805fe0acbaa 117
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells., file e27ce42f-6b49-2581-e053-d805fe0acbaa 92
Activation of RAS family members confers resistance to ROS1 targeting drugs., file e27ce427-03f3-2581-e053-d805fe0acbaa 91
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts, file e27ce431-0751-2581-e053-d805fe0acbaa 80
Patient-derived cancer models, file e27ce431-17cc-2581-e053-d805fe0acbaa 74
Molecularly targeted therapies for gastric cancer. State of the art, file e27ce432-7677-2581-e053-d805fe0acbaa 68
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors., file e27ce426-ca6d-2581-e053-d805fe0acbaa 62
The landscape of d16HER2 splice variant expression across HER2-positive cancers, file e27ce42f-f9f1-2581-e053-d805fe0acbaa 60
Only a subset of Met-activated pathways are required to sustain oncogene addiction, file e27ce426-c444-2581-e053-d805fe0acbaa 56
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas, file e27ce432-759d-2581-e053-d805fe0acbaa 53
The tetraspanin CD151 is required for met-dependent signaling and tumor cell growth, file e27ce426-cb47-2581-e053-d805fe0acbaa 51
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer, file e27ce433-8dbb-2581-e053-d805fe0acbaa 49
Autocrine signaling of NRP1 ligand galectin-1 elicits resistance to BRAF-targeted therapy in melanoma cells, file e27ce432-4d51-2581-e053-d805fe0acbaa 42
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study, file e27ce42c-7f58-2581-e053-d805fe0acbaa 35
Enhanced c-Met activity promotes G-CSF induced mobilization of hematopoietic progenitor cells via ROS signaling., file e27ce426-bea6-2581-e053-d805fe0acbaa 34
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer., file e27ce426-e096-2581-e053-d805fe0acbaa 22
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts, file e27ce431-0557-2581-e053-d805fe0acbaa 22
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts, file 52c30ba5-92de-4264-8774-48ec22157379 19
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers, file e27ce435-48c8-2581-e053-d805fe0acbaa 18
Targeted therapies in cancer and mechanisms of resistance., file e27ce426-ef90-2581-e053-d805fe0acbaa 14
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence., file e27ce426-f472-2581-e053-d805fe0acbaa 14
HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial, file 87e000eb-c317-4ed5-89ba-d74138787577 12
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas, file e27ce435-9762-2581-e053-d805fe0acbaa 11
The importance of being CAFs (in cancer resistance to targeted therapies), file f01d5f66-9da2-435d-82ec-4d28676e6d21 9
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits, file e27ce42f-0282-2581-e053-d805fe0acbaa 7
Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review, file e27ce430-e119-2581-e053-d805fe0acbaa 4
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer, file a3476429-174d-4de8-9faa-f2f292ff8abe 3
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer, file bc30e98f-bce2-4f3f-8c22-a3387201ebd3 3
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors, file de8bf275-2b9f-4f0d-b7bd-f97ce3cfc3be 3
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study, file e27ce42c-8b69-2581-e053-d805fe0acbaa 3
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies, file e27ce432-5941-2581-e053-d805fe0acbaa 2
Only a subset of Met-activated pathways are required to sustain oncogene addiction, file e27ce426-c443-2581-e053-d805fe0acbaa 1
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition., file e27ce426-ca71-2581-e053-d805fe0acbaa 1
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort, file e27ce429-be4c-2581-e053-d805fe0acbaa 1
Totale 3.018
Categoria #
all - tutte 5.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201982 0 0 0 0 0 0 0 0 0 0 48 34
2019/2020340 30 21 24 46 27 29 30 28 37 18 20 30
2020/2021447 15 44 26 57 28 25 87 24 35 34 32 40
2021/2022815 67 50 62 72 86 51 67 68 51 40 132 69
2022/2023621 30 47 114 82 46 48 67 35 61 39 31 21
2023/2024243 13 17 40 18 24 20 34 26 11 35 5 0
Totale 3.018